NVS : Novartis AG
Sector: Healthcare > Industry: Major Drugs
Novartis AG, included 29 February 1996, is a Swiss-based holding, which the, through its branches, busy in research, development, manufacturing and marketing of healthcare products. The Company's healthcare portfolio includes medicines, preventive vaccines and diagnostic tools, generic pharmaceuticals and consumer care products. His firms are internationally divided into four operating divisions: Pharmaceuticals, which includes the brand name, patented pharmaceuticals; Vaccines and Diagnostics, which focuses on human vaccines and blood-testing diagnostics; sandoz, which consists of generic pharmaceuticals, and Consumer Health, which includes over-the-counter medications, animal health medicines, and care products lenses and contact lenses. This works in approximately 140 countries.
7 April 2008, Novartis AG announced, that the agreement with the Harbored Securities Act, under which it obtained the rights to acquire the two controlling interests of the steps of Alcon Inc., the first step was over 7 July 2008, when Novartis acquired the initial stake in 24.8 % в Alcon Inc. 17 July 2008, acquired Pharmaceuticals Protez, biopharmaceuticals company, and accessed PTZ601, a Phase II antibiotic against potentially fatal drug-resistant bacterial infections. 10 July 2008, it acquired a majority stake in Speedel Holding AG, Swiss pharmaceutical company, and committed to acquire all remaining shares in a compulsory public tender. In July, Novartis AG entered into a strategic partnership with Lonza, a Swiss pharmaceutical manufacturer. 31 December 2008, The company acquired Nektar Therapeutics Inc's pulmonary business unit.
The Company's product portfolio includes Diovan together with Diovan HCT / Co-Diovan, which are medicines for high blood pressure; Gleevec/Glivec – signal transduction inhibitor, одобренный, to treat certain forms of chronic myeloid leukemia (COMMERCIAL) and gastrointestinal stromal tumors; Zometa – treating certain cancers, which have spread to the bones, approved for the treatment of patients with multiple myeloma and patients with documented bone metastasis from solid tumors, including prostate, chest and lung tumors; Femara – a once daily oral aromatase inhibitor for the treatment of early stage or advanced breast cancer in postmenopausal women, among the others.
Pharmaceuticals Division
The Pharmaceuticals Division investigates, Develops, Produces, distributes, and sells branded pharmaceuticals in the following therapeutic areas: cardiovascular and metabolism; oncology; neurology and ophthalmics; respiratory; immunology and infectious diseases; and another. The Pharmaceuticals Division is organized into global business franchises, responsible for the marketing of various products, same as Novartis Oncology business unit, responsible for global development and marketing of oncology products
Vaccines and Diagnostics Division
The Vaccines and Diagnostics Division investigates, Develops, Produces, distributes, and sells preventive vaccine treatments and diagnostic tools. The unit has two actions: Vaccines Novartis and Chiron. Key foods include flu, meningococcal, pediatric and vaccine travel. Chiron – blood testing and molecular diagnostics activities, dedicated to preventing the spread of infectious diseases through the development of new blood-screening instruments, which protect the world's blood supply.
Division Sandoz
Division Sandoz – generic pharmaceuticals company, which develops, Produces, distributes, and sells drugs along with pharmaceutical and biotechnological active substances. The Sandoz Division has operations in Retail Generic, Anti-Infectives и Biopharmaceuticals. In Retail Generic, Sandoz develops and manufactures active ingredients and complete pharmaceutical dosage forms, more patented, as well as the supply of active ingredients to third parties. At Anti-Infectives Sandoz develops and manufactures inaccessible active pharmaceutical ingredients and intermediates, mainly antibiotics, for retail use Generic and for sale to third party customers. At Biopharmaceuticals Sandoz develops and produces protein – or biotechnology-based products, more protected by patents and provide the production of biotechnology to other companies on the basis of a contract. Sandoz offers approximately 950 compositions in more than 5 000 forms in 130 countries.
Consumer Health Division
The Consumer Health Division consists of three business units: over-the-counter drugs (over-the-counter network of securities dealers), Animal Health & Vision CIBA. An over-the-counter network of securities dealers offers over-the-counter medication alone. Animal Health provides veterinary products to companion animals and the farm. Markets Contact Lenses CIBA Vision and Lens Care Products.
